Ms. SUNRAY LEE | Molecular Biology | Best Researcher Award
Research Director at CEFObio Co., Ltd , South Korea.
Dr. Sunray Lee is a distinguished researcher and Director of CEFO Research Institute in Seoul, Korea . With a Ph.D. in Stem Cell Biology from Korea University
, his expertise spans molecular immunology, MHC biology, and regenerative medicine
. Over two decades, he has led pivotal R&D in stem cells, biomaterials, and cell therapy
. As a prolific author and patent holder, Dr. Lee’s innovations have influenced cosmetic biotechnology, bone regeneration, and 3D cell culture
. He is a regular member of national innovation committees and an active contributor to international conferences and regenerative medicine networks
.
PROFILE
Dr. Sunray Lee embodies the ideal candidate for a Best Researcher Award through his unmatched dedication, multidisciplinary expertise, and leadership in regenerative medicine, stem cell biology, and biomaterials research. With over 20 years of experience and numerous high-impact publications, his work bridges science and innovation, directly contributing to advancements in clinical and cosmetic therapeutics. He has led transformative R&D, mentored scientific communities, and represented Korea in international regenerative medicine collaborations.
Education
-
B.Sc. in Agronomy – Korea University (1995–1999)
-
M.Sc. in Molecular & Cellular Immunology – Korea University (2000–2003)
-
Ph.D. in MHC & Stem Cell Biology – Korea University (2006–2012)
Professional Experience
-
Researcher, MHC Lab, Seoul National University (2004–2005)
-
Senior Scientist, MizMedi Hospital (2005–2007)
-
Senior Scientist, MCTT Research Institute (2007–2011)
-
Member, KEIT Innovation Evaluation (2010–2025)
-
Director, CEFO Research Institute (2012–Present)
-
Committee Member, KSMCB, KSB, KSSCR, CARM, APACRM (2017–Present)
Professional Development 

Dr. Sunray Lee’s professional growth is rooted in cross-disciplinary research, collaborative leadership, and regulatory insight . He is deeply involved in Korea’s R&D planning and policy through KEIT and serves as Vice Chair at CARM’s International Cooperation Committee
. His participation in global forums like APACRM and KSSCR highlights his dedication to regenerative medicine diplomacy
. Dr. Lee frequently delivers keynote talks and publishes cutting-edge research in journals spanning biomedical engineering, dermatology, and pharmaceuticals
. He continuously fosters innovation through industry-academia linkages and promotes ethical advancement in biotechnology and stem cell research
.
Research Focus
Dr. Lee’s research revolves around regenerative medicine, focusing on stem cell biology, biomaterials, and cellular therapy . His work includes developing 3D cell culture systems, cryopreservation methods, and stem cell-based skin and bone therapies
. A major emphasis lies in mesenchymal stem cells, pluripotent stem cells, and their therapeutic applications in cosmetics and orthopedics
. His projects combine bioengineering, molecular biology, and omics to optimize cell culture environments and develop innovative treatment platforms
. With a vision toward translational medicine, he contributes to national and international standards for advanced regenerative products and clinical protocols
.
Awards and Honors 

-
Citation by Ministry of Trade, Industry & Energy (MOTIE) – Dec. 12, 2018
-
Best Investigator Award, Korea University – Mar. 27, 2012
Publications & Citations 
-
-
2025 –
Development of Mold Technology for Insert-Wells
-
2024 –
Cell Therapy Using Umbilical Cord MSCs for Osteonecrosis
-
2023 –
Osteogenic-Induced Adipose Stem Cells in Canine Bone Repair
-
2023 –
Stem Cell-Conditioned Medium for Whitening & Moisturizing
-
2023 –
Tracking HUVECs Using Quantum Dot Nanoparticles
-
2023 –
Asia Guidelines for Ancillary Materials in Cell Therapy
-
2022 –
Cryogenic Storage Container Cell Viability Study
-
2022 –
3D Stem Cell Cream Effects on Skin Elasticity
-
2020 –
Anti-aging Effects of Stem Cell Creams
-
2020 –
Medroxyprogesterone & Metformin in Endometrial Cancer
-
2020 –
Cryogenic Container Plastic Changes Analysis
-
2020 –
3D Co-culture to Enhance Drug Selectivity
-
2020 –
Cosmetic Products with MSC Medium
-
2019 –
Equine iPSCs for Therapeutic MSC Differentiation
-
2019 –
Immune Effects of 3D MSC Conditioned Cream
-
2018 –
Induced Myogenic Stem Cells via Transcription Factors
-
2016 –
Apoptin Gene Delivery for Glioma Cells
-
2016 –
Glycol Chitosan-PEI Gene Carrier for MSCs
-
2016 –
PAMAM Dendrimers for Gene Delivery to MSCs
-
2012 –
DNA Methylation in Pluripotent Stem Cells
-
2011 –
Stem Cell Substrate Physical Properties
-
2011 –
Dental Stem Cell Comparisons
-
2011 –
Dynamic Gene Copy Number Changes in iPSCs
-
2010 –
Adipogenic Differentiation in Feeder Cells
-
2010 –
Umbilical MSCs as Therapy
-
2009 –
MSC Source Phenotypic Analysi
-
2004 –
Promyelocytic Leukemia & SAPK2 Inhibition
-
2004 –
CMV and MHC Class I Immune Evasion
-
2004 –
HLA-G Shedding & NK Cell Inhibition
-
Conclusion:
Dr. Sunray Lee’s consistent pursuit of excellence, coupled with tangible contributions to science, medicine, and technology, makes him not just a candidate—but a model recipient—for the Best Researcher Award. His innovative mindset, translational achievements, and leadership in stem cell applications mark him as a cornerstone in modern biomedical research .